We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

3D Mammography Significantly Reduces Breast Biopsy Rates

News   Mar 19, 2019 | Original story from RSNA

 
3D Mammography Significantly Reduces Breast Biopsy Rates

Images in a 63-year-old asymptomatic woman who was recalled because a new 8-mm mass was detected in the left breast at screening mam¬mography. (a) Left mediolateral oblique and (b) left mediolateral oblique spot compression mammograms show an 8-mm partly ill-defined mass (arrow) in the upper breast. (c) Left mediolateral oblique digital breast tomosynthesis (DBT) image shows an 8-mm well-defined mass (arrow) in the upper breast. The mass was interpreted as benign at DBT and was coded R2 benign; however, it was indeterminate at full-field digital mammography. Targeted US of the breast revealed normal findings, and stereotactic biopsy yielded a diagnosis of micropapillary ductal carcinoma in situ (DCIS). Wide local surgical exci¬sion revealed a 5-mm high-grade DCIS. Credit: Radiological Society of North America

 
 
 

RELATED ARTICLES

Study Finds Commercially Available Antibodies Are Not Binding Their Target

News

In a new study, researchers have tested the binding specificity of commercial antibodies to the C9ORF72 protein, and explored a novel validation approach.

READ MORE

Will a Next-generation Therapy for Diabetes Soon Be Available?

News

In order to improve diabetes therapy, researchers at the University of Geneva (UNIGE), Switzerland, have identified a protein called S100A9 which, under certain conditions, seems to act as a blood sugar and lipid regulator while avoiding the most harmful side effects of insulin.

READ MORE

Personalized Immunotherapy Refined by Mass Spec-Machine Learning Pairing

News

A combination of mass spectrometry and a novel computational tool is more accurately identifying the molecular signs of cancer likely to be presented to helper T cells, which stimulate and orchestrate the immune response to tumors and infectious agents.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE